scispace - formally typeset
C

Charles A. Dinarello

Researcher at University of Colorado Denver

Publications -  1073
Citations -  152254

Charles A. Dinarello is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Interleukin & Cytokine. The author has an hindex of 190, co-authored 1058 publications receiving 139668 citations. Previous affiliations of Charles A. Dinarello include University of Guadalajara & Pennsylvania State University.

Papers
More filters
Journal ArticleDOI

Resistant Behçet disease responsive to anakinra.

Costantino Botsios, +4 more
- 19 Aug 2008 - 
Journal ArticleDOI

Alarmins: Feel the Stress.

Peleg Rider, +4 more
- 15 Feb 2017 - 
TL;DR: This article suggests a novel activity of these molecules as central initiators of sterile inflammation in response to nonlethal stress, a function the authors denote “stressorins,” and highlights the role of posttranslational modifications of stressorins as key regulators of their activity.
Journal Article

Induction of circulating IL-1 receptor antagonist by IFN treatment.

H Tilg, +7 more
- 15 May 1993 - 
TL;DR: The induction of IL-1Ra may contribute to the antiviral, anti-inflammatory, and antiproliferative effects of IFN.
Journal ArticleDOI

The natural interleukin-1 receptor antagonist in tem and preterm parturition

Roberto Romero, +6 more
- 01 Oct 1992 - 
TL;DR: Amniotic fluid contains the highest interleukin-1 receptor antagonist concentrations detected in any biologic fluid to date and exogenous anticytokine agents may be of value in the treatment of preterm labor.
Journal ArticleDOI

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.

A. Mario Q. Marcondes, +5 more
- 26 Feb 2008 - 
TL;DR: It is proposed that IL-32 is a marrow stromal marker that distinguishes patients with myelodysplastic syndrome and chronic myelomonocytic leukemia and may be a therapeutic target.